Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)

Clinical trial NCT05382364 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05382364
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic HER2+ Advanced Breast Cancer Breast Neoplasms Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)Colorectal Cancer

Start date: 2022-06-29
Primary completion: 2026-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.